Intrigued by the apparent requirement of dithionite for FMN reduction (as opposed to photoreduction or catalytic hydrogenation) in the H 2 O 2 ‐initiated bacterial bioluminescence reaction, we chose 5‐ethyl‐3‐methyllumiflavinium cation I as a mode) to investigate possible flavin adduct formation by treatment with dithionite or (bi)sulfite. In the range of pH5–8, the reaction of dithionite with 5‐ethyl‐3‐methylIumiflavinium cation, which is in equilibrium with the 5‐ethyl‐4 a ‐hydroxy‐3‐methyl‐4 a , 5‐dihydrolumiflavin pseudobase II (X = OH), is not limited to the formation of flavo‐semiquinone and dihydroflavin following two one‐electron steps. Several parallel and sequential reactions may take place involving the intermediacy of covalent flavin adducts. Addition of (bi)sulfite gave a 4 a ‐sulfiteflavin adduct II (X = SO3). Consistent with the S 2 O4 ⇄ 2 SO2 equilibrium, the reaction of dithionite and II (X = OH; SO3) gave rise to two flavin adducts in competitive nucleophilic displacements: a 4 a ‐sulfoxylate‐flavin radical (II, X = SO 2 ) and a 4 a ‐dithioniteflavin adduct (II, X = S 2 O4), respectively. On increasing the (S 2 O4, SO2)/f1avin ratio under N 2 , the formation of the 4 a ‐sulfoxylate‐flavin radical became predominant. The II (X = SO2) so formed was in equilibrium with the flavosemiquinone and bisulfite and can be trapped by reacting with hydroxylamine. In the initial presence of oxygen, II (X = SO 2 ) was highly reactive toward O2, giving a fast oxidation to II (X = SO3) and effectively suppressing the formation of the flavosemiquinone. If the oxygen is subsequently removed, the II (X = SO3) so formed then reacts with dithionite leading to quantitative accumulation of II (X = S 2 O4). Slow, spontaneous decompositions of the 4 a ‐dithioniteflavin adduct indicated the occurrence of alternative pathways, probably proceeding via a 4 a ‐sulfoxylateflavin anion (II, X = SO2) and II (X = SO 2 ) as intermediates. The implications of these findings for the reactions of (bi)sulfite and dithionite with (dihydro)flavodoxins and for the role of dithionite in the H 2 O 2 induced bacterial bioluminescence are discussed.
No takes yet. Share an insight, caveat, or question.
Mager et al. (1990) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: